It was further revealed that lower ISL1 transcript expression was significantly correlated with poorer survival in breast cancer patients (p < 0.05); however, it was not demonstrated whether DNMT1 expression was inversely correlated in breast cancer patients [142]. This evidence concerns the gene ISL1 and breast cancer.